Synthetic lethality of ERBB2 and CCND1 in breast cancer at scale

Authors: Rishi Nair, Evan P White, Roy Khalife, Anthony M Magliocco
Journal: Molecular Cancer Therapeutics | Volume 23, Issue 6_Supplement
Publisher: The American Association for Cancer Research

Anthony MaglioccoJune 10, 2024

Incidence of Breast Cancer in Hispanic Women Across the US: A Focus on Texas

Authors: Catalina Esguerra, Kemely Santos Barbosa, Roy Khalife, Anthony Magliocco
Journal: Cancer Research (2024) 84 (9_Supplement): PO5-09-09
Publisher: The American Association for Cancer Research

Anthony MaglioccoMay 2, 2024

Validation of Aventa FusionPlus: An LDT NGS assay for comprehensive cancer genomic profiling

Authors: Shadi Melnyk, Jon Belton, Sofia Nomikou, Katelyn Powell, Daniel Heiney, Roy Khalife, Damien Jones, Anthony Schmitt, Catherine Wilson, Melissa Won, Anthony Magliocco, Chris Roberts
Journal: Cancer Research (2024) 84 (6_Supplement): 325.
Publisher: The American Association for Cancer Research

Anthony MaglioccoMarch 22, 2024

Genetic characteristics between males and females with urothelial bladder cancer

Authors: Rishi Nair, Roy Khalife, Anthony Magliocco
Journal: Cancer Research (2024) 84 (6_Supplement): 883.
Publisher: The American Association for Cancer Research

Anthony MaglioccoMarch 22, 2024

What can we learn from a retrospective evaluation of HER2, P53 and P16INK4A protein expression in rare ovarian tumors?

Authors: Kavitha M. Advikolanu-Rao; Anthony M. Magliocco; Andrew W. Maksymiuk
Journal: Cancer Research (2024) 84 (5_Supplement_2): A063.
Publisher: The American Association for Cancer Research

Anthony MaglioccoMarch 4, 2024

Comparing Classifications from Multiple Variant Annotation Software Solutions Using Real-World Next Generation Sequencing Data from Oncology Testing

Authors: Roy Khalife, Tara M. Love, Lara Sucheston-Campbell, Michael J. Clark, Helle Sorensen, Shuba Krishna, Anthony Magliocco
Journal: Journal of Molecular Pathology | 2024, 5(1), 81-95
Publisher: MDPI

Anthony MaglioccoMarch 3, 2024